264 related articles for article (PubMed ID: 26944411)
21. CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer.
Buldakov M; Zavyalova M; Krakhmal N; Telegina N; Vtorushin S; Mitrofanova I; Riabov V; Yin S; Song B; Cherdyntseva N; Kzhyshkowska J
Immunobiology; 2017 Jan; 222(1):31-38. PubMed ID: 26391151
[TBL] [Abstract][Full Text] [Related]
22. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
23. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages.
Alkhateeb AA; Han B; Connor JR
Breast Cancer Res Treat; 2013 Feb; 137(3):733-44. PubMed ID: 23306463
[TBL] [Abstract][Full Text] [Related]
24. Rocaglamide regulates iron homeostasis by suppressing hepcidin expression.
Zhu X; Zuo Q; Xie X; Chen Z; Wang L; Chang L; Liu Y; Luo J; Fang C; Che L; Zhou X; Yao C; Gong C; Hu D; Zhao W; Zhou Y; Zhu S
Free Radic Biol Med; 2024 Jul; 219():153-162. PubMed ID: 38657753
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment.
Sanguinetti A; Santini D; Bonafè M; Taffurelli M; Avenia N
World J Surg Oncol; 2015 Mar; 13():129. PubMed ID: 25881039
[TBL] [Abstract][Full Text] [Related]
26. Effects of alpha-lipoic acid on expression of iron transport and storage proteins in BV-2 microglia cells.
Chen P; Li FM; Zhou YF; Qian C; Li J; Jiang LR; Qian ZM
Pharmacol Rep; 2017 Feb; 69(1):1-5. PubMed ID: 27755990
[TBL] [Abstract][Full Text] [Related]
27. Ferroportin and iron regulation in breast cancer progression and prognosis.
Pinnix ZK; Miller LD; Wang W; D'Agostino R; Kute T; Willingham MC; Hatcher H; Tesfay L; Sui G; Di X; Torti SV; Torti FM
Sci Transl Med; 2010 Aug; 2(43):43ra56. PubMed ID: 20686179
[TBL] [Abstract][Full Text] [Related]
28. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
Urrutia P; Aguirre P; Esparza A; Tapia V; Mena NP; Arredondo M; González-Billault C; Núñez MT
J Neurochem; 2013 Aug; 126(4):541-9. PubMed ID: 23506423
[TBL] [Abstract][Full Text] [Related]
29. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor protects PC12 cells against OGD/R-induced injury by reducing iron.
Li S; Qian ZM; Xu G; Zheng J; Wu Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32186328
[TBL] [Abstract][Full Text] [Related]
31. An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis.
Guo W; Zhang S; Chen Y; Zhang D; Yuan L; Cong H; Liu S
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):703-15. PubMed ID: 26201356
[TBL] [Abstract][Full Text] [Related]
32. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
[TBL] [Abstract][Full Text] [Related]
33. B7-H4 expression in human infiltrating ductal carcinoma‑associated macrophages.
Liu L; Li D; Chen S; Zhao R; Pang D; Li D; Fu Z
Mol Med Rep; 2016 Sep; 14(3):2135-42. PubMed ID: 27430170
[TBL] [Abstract][Full Text] [Related]
34. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
36. Substantial changes of cellular iron homeostasis during megakaryocytic differentiation of K562 cells.
Wandzik K; Zahn C; Dassler K; Fuchs H
Dev Growth Differ; 2009 Aug; 51(6):555-65. PubMed ID: 21314673
[TBL] [Abstract][Full Text] [Related]
37. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
[TBL] [Abstract][Full Text] [Related]
38. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.
Chung W; Eum HH; Lee HO; Lee KM; Lee HB; Kim KT; Ryu HS; Kim S; Lee JE; Park YH; Kan Z; Han W; Park WY
Nat Commun; 2017 May; 8():15081. PubMed ID: 28474673
[TBL] [Abstract][Full Text] [Related]
39. FAS and FAS-L expression by tumor cells and lymphocytes in breast carcinomas and their lymph node metastases.
Ioachim HL; Decuseara R; Giancotti F; Dorsett BH
Pathol Res Pract; 2005; 200(11-12):743-51. PubMed ID: 15792116
[TBL] [Abstract][Full Text] [Related]
40. BCL-6 oncoprotein in breast cancer: loss of expression in disease progression.
Pinto AE; André S; Silva G; Vieira S; Santos AC; Dias S; Soares J
Pathobiology; 2009; 76(5):235-42. PubMed ID: 19816083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
